Published in Blood Weekly, May 31st, 2007
"The estimated 3-year survival rates were 72% in 88 patients who progressed in chronic phase, 30% in 130 patients who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.